Detalhe da pesquisa
1.
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.
Blood
; 129(26): 3419-3427, 2017 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424162
2.
Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia.
Blood
; 125(3): 492-8, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25377784
3.
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome.
Hematol Oncol
; 40(2): 302-306, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34806797
4.
Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.
Am J Hematol
; 92(8): 759-763, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28402581
5.
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.
Blood
; 117(6): 1928-37, 2011 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21135257
6.
Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.
Blood
; 115(9): 1755-64, 2010 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20018914
7.
B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells.
Blood Cancer J
; 12(7): 99, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778390
8.
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells.
Blood
; 113(22): 5568-74, 2009 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-19336759
9.
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab.
Blood
; 113(3): 535-7, 2009 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19008456
10.
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.
Blood Cancer J
; 11(5): 86, 2021 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972504
11.
Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia.
Br J Haematol
; 169(3): 445-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25382417
12.
Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.
Clin Cancer Res
; 15(4): 1250-8, 2009 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19228728
13.
Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia.
Br J Haematol
; 146(6): 660-4, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19604237
14.
Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis.
Br J Haematol
; 164(1): 146-50, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24111951
15.
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.
Br J Haematol
; 147(4): 471-83, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19751240
16.
Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patients.
Leukemia
; 33(3): 638-652, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30291337
17.
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab.
Leuk Res
; 32(12): 1849-56, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18584865
18.
Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy.
Oncotarget
; 9(98): 37173-37184, 2018 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30647852
19.
Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis.
J Nanobiotechnology
; 5: 4, 2007 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-17488514
20.
Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells.
Leuk Lymphoma
; 57(10): 2409-16, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27189785